Position in OPK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$101,388
-$14,156 QoQ
Shares Held
88,937
-3.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OPK Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Quadrature Capital Ltd holds $1,206,303 across 6 Diagnostics & Research names. OPK ranks #6 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FLGT |
Fulgent Genetics, Inc.
|
19,640 | $312,276 | |
| 2 | PSNL |
Personalis, Inc.
|
38,722 | $246,659 | |
| 3 | VCYT |
Veracyte, Inc.
|
7,594 | $244,602 | |
| 4 | ADPT |
Adaptive Biotechnologies Corp
|
12,387 | $171,931 | |
| 5 | MYGN |
Myriad Genetics Inc
|
28,766 | $129,447 | |
| 6 | OPK |
Opko Health, Inc.
This page
|
88,937 | $101,388 |
All Filings in OPK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $101,388 | 88,937 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $115,544 | 91,702 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $128,912 | 77,658 | Shares | Other | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||